Live Breaking News & Updates on Incu Bio Program Of The Hong Kong Science

Stay updated with breaking news from Incu bio program of the hong kong science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

HKBU develops dual-targeting drug for EBV-related cancers

Hong Kong Baptist University
A Hong Kong Baptist University-led (HKBU) research team has developed a novel drug which has thepotential to become a
next-generation treatment for cancers associated with Epstein–Barr virus (EBV).
The peptide-linked drug, which is responsive to the acidic environment found in tumours, is the first known agent to have
successfully targeted two viral proteins that are simultaneously produced by EBV. It also offers a new strategy by increasing the uptake of anti-cancer drugs in tumour cells, thus
allowing the application of lower drug dosages which helps reduce treatment side effects and health risks.
The research results were published in the international academic journal ....

Hong Kong , Hong Lok , Gary Wong Ka Leung , Third Affiliated Hospital At Sun Yat Sen University , Hong Kong Polytechnic University , Chemical Technology , Incu Bio Program Of The Hong Kong Science , Bp Innomed Limited , Head Of The Department Chemistry , Asian Fund For Cancer Research , Technology Park , Professor Of The Department Applied Biology , Professor Of The Department Chemistry , Hong Kong Baptist University Led , Professor Gary Wong Ka Leung , Assistant Professor , Associate Professor , Applied Biology , Med Limited , Best Public Communicator , Cancer Entrepreneurship Venture Competition , Asian Fund , Incu Bio Program , Hong Kong Science , Third Affiliated Hospital , Sun Yat Sen ,

HKBU develops dual-targeting drug for EBV-related cancers

HKBU develops dual-targeting drug for EBV-related cancers
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Hong Kong , Kostenloser Wertpapierhandel , Hong Lok , Gary Wong Ka Leung , Third Affiliated Hospital At Sun Yat Sen University , Hong Kong Polytechnic University , Chemical Technology , Incu Bio Program Of The Hong Kong Science , Bp Innomed Limited , Asian Fund For Cancer Research , Head Of The Department Chemistry , Technology Park , Professor Of The Department Applied Biology , Professor Of The Department Chemistry , Public Relations Office , Hong Kong Baptist University Led , Professor Gary Wong Ka Leung , Assistant Professor , Associate Professor , Applied Biology , Med Limited , Best Public Communicator , Cancer Entrepreneurship Venture Competition , Asian Fund , Incu Bio Program , Hong Kong Science ,

HKBU develops dual-targeting drug for EBV-related cancers

HKBU develops dual-targeting drug for EBV-related cancers
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Hong Kong , Hong Lok , Gary Wong Ka Leung , Third Affiliated Hospital At Sun Yat Sen University , Hong Kong Polytechnic University , Hong Kong Baptist University , Chemical Technology , Incu Bio Program Of The Hong Kong Science , Bp Innomed Limited , Head Of The Department Chemistry , Asian Fund For Cancer Research , Technology Park , Professor Of The Department Applied Biology , Public Relations Office , Professor Of The Department Chemistry , Professor Gary Wong Ka Leung , Assistant Professor , Associate Professor , Applied Biology , Med Limited , Best Public Communicator , Cancer Entrepreneurship Venture Competition , Asian Fund , Incu Bio Program , Hong Kong Science , Third Affiliated Hospital ,